1. DOP45 Predicting late responders to filgotinib in patients with moderately to severely active Ulcerative Colitis: A post hoc analysis of SELECTION and SELECTIONLTE. (30th January 2023) Authors: Matsuoka, K; Löwenberg, M; Fumery, M; Takatori, Y; Fujitani, Y; Oortwijn, A; Faes, M; Jamoul, C; Hibi, T Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P319 Characteristics of filgotinib-treated patients with Ulcerative Colitis who achieve sustained corticosteroid-free remission: Post hoc analysis of the phase 2b/3 SELECTION study. (30th January 2023) Authors: Kobayashi, T; Dignass, A; Roblin, X; Fujitani, Y; Oortwijn, A; Jamoul, C; Hibi, T Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗